newsfilter
← Latest News
PR Newswire·

Compugen to Participate in Stifel 2025 Healthcare Conference

Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in predictive computational drug target...